Quick Answer
Vicapsys Life Sciences, Inc. reported Common Stock Shares Outstanding of 32.07 million shares for the year ending 2023.
- Vicapsys Life Sciences, Inc. showed an increase of +2.8% in Common Stock Shares Outstanding from 2022 to 2023.
- This data is from Vicapsys Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on October 21, 2024.
- XBRL data for this metric is available from 2019 to 2023 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: 17.48 million shares | Q2 2020: 17.48 million shares | Q3 2020: 17.48 million shares | Q1 2021: 17.51 million shares | Q2 2021: 17.51 million shares | Q3 2021: 17.51 million shares | Q1 2022: 31.19 million shares | Q2 2022: 31.19 million shares | Q3 2022: 31.19 million shares | Q1 2023: 31.19 million shares | Q2 2023: 31.19 million shares | Q3 2023: 32.07 million shares | Q4 2023: 32.07 million shares | Q1 2024: 32.07 million shares | Q2 2024: 32.07 million shares | Q3 2024: 32.37 million shares.
- Over the full 5 years of available data (2019 to 2023), Vicapsys Life Sciences, Inc.'s Common Stock Shares Outstanding has grown by 83.4%.
- Historical annual values: Fiscal year 2023: 32.07 million shares | Fiscal year 2022: 31.19 million shares | Fiscal year 2021: 19.75 million shares | Fiscal year 2020: 17.48 million shares | Fiscal year 2019: 17.48 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: